Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
Price:
3.87
USD
7.5%
Market Closed
Market Cap:
$637m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
|
US |
|
M
|
Magnum Ice Cream Company NV
AEX:MICC
|
NL |
|
P
|
PCCW Ltd
OTC:PCWLF
|
HK |
|
Emerald Resources NL
ASX:EMR
|
AU |
Wall St Price Targets
IRWD Price Forecast
Based on 6 analysts
Based on 6 analysts
+41% Upside
from
$3.87
today
Ironwood Pharmaceuticals Inc (IRWD)’s 12-month stock price forecast through October 2027 has a consensus target of $5.46, implying 41% upside. The forecast is based on price targets from 6 Wall Street analysts.
IRWD Analyst Rating
Based on 4 analysts
Based on 4 analysts
Analysts rate IRWD Buy, with 2 of 4 recommending Buy or Strong buy.
Ironwood Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IRWD's stock price target?
Price Target
5.46
USD
5.46
USD
According to Wall Street analysts, the average 1-year price target for IRWD is 5.46 USD with a low forecast of 3.74 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for Ironwood Pharmaceuticals Inc?
Projected CAGR
-3%
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is -3%.
What is the Operating Income forecast for Ironwood Pharmaceuticals Inc?
Projected CAGR
-13%
-13%
The compound annual growth rate for Operating Income over the next 8 years is -13%.
What is the Pre-Tax Income forecast for Ironwood Pharmaceuticals Inc?
Projected CAGR
69%
69%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 69%.
What is the Net Income forecast for Ironwood Pharmaceuticals Inc?
Projected CAGR
7%
7%
The compound annual growth rate for Net Income over the next 8 years is 7%.